Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-02 Sale |
2025-01-03 5:05 pm |
Athira Pharma Inc. | ATHA | San Martin Javier CHIEF MEDICAL OFFICER |
10,826 | $0.5619 | $6,083 | 129,174 (Direct) |
View |
| 2025-01-02 Sale |
2025-01-03 5:04 pm |
Athira Pharma Inc. | ATHA | Litton Mark James President and CEO |
25,107 | $0.5619 | $14,108 | 478,947 (Indirect Direct) |
View |
| 2025-01-02 Sale |
2025-01-03 5:03 pm |
Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER |
8,510 | $0.5619 | $4,782 | 204,094 (Direct) |
View |
| 2025-01-02 Sale |
2025-01-03 5:01 pm |
Athira Pharma Inc. | ATHA | Renninger Robert VP of Finance |
2,881 | $0.5619 | $1,619 | 114,442 (Direct) |
View |
| 2025-01-02 Sale |
2025-01-03 5:00 pm |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO |
8,510 | $0.5619 | $4,782 | 157,068 (Direct) |
View |
| 2024-09-05 Sale |
2024-09-05 7:51 pm |
Athira Pharma Inc. | ATHA | Gengos Andrew CFO and Chief Business Officer |
1,272 | $0.566 | $720 | 97,532 (Direct) |
View |
| 2024-09-05 Sale |
2024-09-05 7:50 pm |
Athira Pharma Inc. | ATHA | Lenington Rachel COO and CDO |
2,525 | $0.566 | $1,429 | 20,870 (Direct) |
View |
| 2024-09-05 Sale |
2024-09-05 7:49 pm |
Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER |
2,525 | $0.566 | $1,429 | 92,684 (Direct) |
View |
| 2024-09-05 Sale |
2024-09-05 7:48 pm |
Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL |
2,525 | $0.566 | $1,429 | 51,927 (Direct) |
View |
| 2024-09-05 Sale |
2024-09-05 7:47 pm |
Athira Pharma Inc. | ATHA | Litton Mark James President and CEO |
5,032 | $0.566 | $2,848 | 179,054 (Indirect Direct) |
View |
| 2024-06-21 Purchase |
2024-06-25 7:21 pm |
Athira Pharma Inc. | ATHA | Romano Kelly A Director |
42,400 | $2.3597 | $100,051 | 80,715 (Direct) |
View |
| 2024-01-05 Sale(A) |
2024-02-16 4:40 pm |
Athira Pharma Inc. | ATHA | Lenington Rachel COO AND CDO |
2,412 | $2.91 | $7,019 | 13,395 (Direct) |
View |
| 2024-01-05 Sale(A) |
2024-02-16 4:38 pm |
Athira Pharma Inc. | ATHA | Litton Mark James CEO |
4,820 | $2.91 | $14,026 | 164,086 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-03 Option Award(A) |
2025-03-12 5:20 pm |
N/A 2035-03-02 |
Athira Pharma Inc. | ATHA | Renninger Robert SVP, Finance and Accounting |
73,350 | $0 | 73,350 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-04 4:31 pm |
N/A 2035-03-02 |
Athira Pharma Inc. | ATHA | Renninger Robert SVP, Finance and Accounting |
170,850 | $0 | 170,850 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-04 4:30 pm |
N/A 2035-03-02 |
Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER |
146,408 | $0 | 146,408 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-04 4:29 pm |
N/A 2035-03-02 |
Athira Pharma Inc. | ATHA | Litton Mark James President and CEO |
556,358 | $0 | 556,358 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-04 4:29 pm |
N/A 2035-03-02 |
Athira Pharma Inc. | ATHA | San Martin Javier CHIEF MEDICAL OFFICER |
185,450 | $0 | 185,450 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-04 4:28 pm |
N/A 2035-03-02 |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO |
143,158 | $0 | 143,158 (Direct) |
View |
| 2024-12-31 Exercise |
2025-01-03 5:05 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | San Martin Javier CHIEF MEDICAL OFFICER |
46,667 | $0 | 129,174 (Direct) |
View |
| 2024-12-31 Exercise |
2025-01-03 5:04 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Litton Mark James President and CEO |
108,333 | $0 | 478,947 (Direct) |
View |
| 2024-11-18 Option Award |
2025-01-03 5:03 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER |
9,920 | $0.55 | 204,094 (Direct) |
View |
| 2024-12-31 Exercise |
2025-01-03 5:03 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER |
36,667 | $0 | 204,094 (Direct) |
View |
| 2024-11-18 Option Award |
2025-01-03 5:01 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Renninger Robert VP of Finance |
3,651 | $0.55 | 114,442 (Direct) |
View |
| 2024-12-31 Exercise |
2025-01-03 5:01 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Renninger Robert VP of Finance |
12,359 | $0 | 114,442 (Direct) |
View |
| 2024-11-18 Option Award |
2025-01-03 5:00 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO |
3,651 | $0.55 | 157,068 (Direct) |
View |
| 2024-12-31 Exercise |
2025-01-03 5:00 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO |
36,667 | $0 | 157,068 (Direct) |
View |
| 2024-10-03 Option Award(A) |
2024-10-03 9:50 pm |
N/A 2034-10-02 |
Athira Pharma Inc. | ATHA | Litton Mark James President and CEO |
325,000 | $0 | 325,000 (Direct) |
View |
| 2024-10-01 Option Award |
2024-10-03 7:17 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Renninger Robert VP of Finance |
74,154 | $0 | 74,154 (Direct) |
View |
| 2024-10-01 Option Award |
2024-10-03 7:13 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | San Martin Javier CHIEF MEDICAL OFFICER |
280,000 | $0 | 280,000 (Direct) |
View |
| 2024-10-01 Option Award |
2024-10-03 7:10 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER |
220,000 | $0 | 220,000 (Direct) |
View |
| 2024-10-01 Option Award |
2024-10-03 7:08 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO |
220,000 | $0 | 220,000 (Direct) |
View |
| 2024-10-03 Option Award |
2024-10-03 7:07 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Litton Mark James President and CEO |
650,000 | $0 | 650,000 (Direct) |
View |
Ownership |
2024-10-03 7:05 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Renninger Robert VP of Finance |
0 | $0 | 291,099 (Direct) |
View |
| 2024-09-03 Option Award |
2024-09-05 7:51 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Gengos Andrew CFO and Chief Business Officer |
5,000 | $0 | 97,532 (Direct) |
View |
| 2024-05-20 Option Award |
2024-09-05 7:51 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Gengos Andrew CFO and Chief Business Officer |
10,000 | $1.34 | 97,532 (Direct) |
View |
| 2024-09-03 Option Award |
2024-09-05 7:50 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Lenington Rachel COO and CDO |
10,000 | $0 | 20,870 (Direct) |
View |
| 2024-09-03 Option Award |
2024-09-05 7:49 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER |
10,000 | $0 | 92,684 (Direct) |
View |
| 2024-05-20 Option Award |
2024-09-05 7:49 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER |
4,953 | $1.34 | 92,684 (Direct) |
View |
| 2024-09-03 Option Award |
2024-09-05 7:48 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL |
10,000 | $0 | 51,927 (Direct) |
View |
| 2024-05-20 Option Award |
2024-09-05 7:48 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL |
10,000 | $1.34 | 51,927 (Direct) |
View |
| 2024-09-03 Option Award |
2024-09-05 7:47 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Litton Mark James President and CEO |
20,000 | $0 | 179,054 (Direct) |
View |
| 2024-05-24 Option Award |
2024-05-24 7:03 pm |
N/A 2034-05-23 |
Athira Pharma Inc. | ATHA | Romano Kelly A Director |
20,900 | $0 | 20,900 (Direct) |
View |
| 2024-05-24 Option Award |
2024-05-24 7:01 pm |
N/A 2034-05-23 |
Athira Pharma Inc. | ATHA | EDELMAN JOSEPH Director |
20,900 | $0 | 20,900 (Direct) |
View |
| 2024-05-24 Option Award |
2024-05-24 7:00 pm |
N/A 2034-05-23 |
Athira Pharma Inc. | ATHA | JOHNSON JAMES A Director |
20,900 | $0 | 20,900 (Direct) |
View |
| 2024-05-24 Option Award |
2024-05-24 6:58 pm |
N/A 2034-05-23 |
Athira Pharma Inc. | ATHA | Kosacz Barbara Director |
20,900 | $0 | 20,900 (Direct) |
View |
| 2024-05-24 Option Award |
2024-05-24 6:56 pm |
N/A 2034-05-23 |
Athira Pharma Inc. | ATHA | Panzara Michael A. Director |
20,900 | $0 | 20,900 (Direct) |
View |
| 2024-05-24 Option Award |
2024-05-24 6:55 pm |
N/A 2034-05-23 |
Athira Pharma Inc. | ATHA | PICKERING GRANT Director |
20,900 | $0 | 20,900 (Direct) |
View |
| 2024-05-24 Option Award |
2024-05-24 6:54 pm |
N/A 2034-05-23 |
Athira Pharma Inc. | ATHA | FLUKE JOHN M JR Director |
20,900 | $0 | 20,900 (Direct) |
View |
| 2024-04-15 Option Award |
2024-04-16 4:37 pm |
N/A 2034-04-14 |
Athira Pharma Inc. | ATHA | San Martin Javier CHIEF MEDICAL OFFICER |
400,000 | $0 | 400,000 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-16 5:05 pm |
N/A 2034-02-14 |
Athira Pharma Inc. | ATHA | Litton Mark James CEO |
650,000 | $0 | 650,000 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 5:01 pm |
N/A 2034-02-13 |
Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL |
220,000 | $0 | 220,000 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 4:54 pm |
N/A 2034-02-13 |
Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER |
220,000 | $0 | 220,000 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 4:48 pm |
N/A 2034-02-13 |
Athira Pharma Inc. | ATHA | Gengos Andrew CFO AND CHIEF BUSINESS OFFICER |
280,000 | $0 | 280,000 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 4:46 pm |
N/A 2034-02-13 |
Athira Pharma Inc. | ATHA | Lenington Rachel COO AND CDO |
300,000 | $0 | 300,000 (Direct) |
View |
| 2024-01-04 Option Award(A) |
2024-02-16 4:40 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Lenington Rachel COO AND CDO |
10,000 | $0 | 13,395 (Direct) |
View |
| 2024-01-04 Option Award(A) |
2024-02-16 4:38 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Litton Mark James CEO |
20,000 | $0 | 164,086 (Direct) |
View |